has Server used IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2012-08-17 (7 years, 86 days) and hosted in Provo United States, server ping response time 129 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Immunetherapeutics keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Immune therapeutics
2 Immune therapeutics inc
3 Immune therapeutics aimt
4 Immune therapeutics stock
5 Immune therapeutics stock price
6 Immune therapeutics inc 2019 news
7 Immune therapeutics news
8 Immune therapeutics address
9 Immune therapeutics lawsuit

Hosting Provider

Region: UT
City: Provo
Postal Code: 84606
Latitude: 40.218101501465
Longitude: -111.61329650879
Area Code: 801
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain

New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently (45 seconds ago) (6 seconds ago) (3 seconds ago) (5 seconds ago) (33 seconds ago) (1 seconds ago) (25 seconds ago) (4 seconds ago) (7 seconds ago) (13 seconds ago) (0 seconds ago) (0 seconds ago) (3 seconds ago) (46 seconds ago) (6 seconds ago) (29 seconds ago) (25 seconds ago) (36 seconds ago) (0 seconds ago)

Results For Websites Listing

Found 72 Websites with content related to this domain, It is result after search with search engine

Home - Immune Therapeutics, Inc. - OTCQB: IMUN Orlando, Fl., January 16, 2019 Immune Therapeutics Inc (OTC-BB IMUN) today announced two peer-reviewed articles on the clinical application of Methionine enkephalin (MENK) are now available online. Or

Management - Immune Therapeutics, Inc. - OTCQB: IMUN

In April of 2016, Immune Therapeutics, Inc. entered into a binding letter of intent with Super T-Cell Cancer Company, a newly formed Chinese corporation, for the acquisition of Chinese Chimeric Super Antigen Receptor T cell (CAR-T) cocktail therapy, Immuno-Oncology patents (pending), manufacturing technology, and clinical data.

Immune Therapeutics Inc. (IMUN) Stock Message Board

A pilot Phase II clinical trial was conducted by Penn State University in children with moderate to severe active Crohn’s disease. Fourteen subjects were enrolled, 12 subjects were randomized and treated with a mean age of 12.3 years (range 8-17 years).

IMUN Stock Price | Immune Therapeutics Inc. Stock Quote (U

Immune Therapeutics Inc. Immune Therapeutics, Inc. is a biopharmaceutical company focuses on the commercialization of affordable non-toxic immunotherapies focused on the activation and rebalancing

IMUN:OTC US Stock Quote - Immune Therapeutics Inc

Immune Therapeutics, Inc. operates as a biotechnology company. The Company focuses on research new treatments and methods for treatment of cancer, HIV/AIDS, and certain other autoimmune and

Aimmune | Food Allergy CODIT Oral Immunotherapy | Home

Aimmune is a biopharmaceutical company and a leader in developing proprietary product candidates to treat severe food allergies. We are leveraging our Characterized Oral Desensitization Immunotherapy (CODIT™) platform for the treatment of peanut and other food allergies.

Immunic Therapeutics - Home - Immunic Therapeutics

Immunic Therapeutics – Home. Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including relapsing-remitting multiple sclerosis, ulcerative colitis, Crohn’s disease, and psoriasis.

Immunotherapeutics | definition of Immunotherapeutics by

a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, announced that it has secured an oral presentation of Phase 1 data from its HB-101 cytomegalovirus (CMV) clinical program including an update on the ongoing Phase 2 trial at the upcoming American

Intrommune Therapeutics

Intrommune Therapeutics is dedicated to simplifying treatment for food allergies by providing safe, effective, and convenient new options for

Recently Analyzed Sites